Jakarta - Delayed Quote IDR

PT. Penta Valent Tbk (PEVE.JK)

212.00 0.00 (0.00%)
At close: April 26 at 4:11 PM GMT+7
Key Events
Loading Chart for PEVE.JK
DELL
  • Previous Close 212.00
  • Open 214.00
  • Bid 216.00 x --
  • Ask 210.00 x --
  • Day's Range 206.00 - 214.00
  • 52 Week Range 135.00 - 216.00
  • Volume 2,193,900
  • Avg. Volume 964,881
  • Market Cap (intraday) 374.311B
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

PT. Penta Valent Tbk distributes pharmaceutical products, medical equipment, and consumer products in Indonesia. The company offers over the counter drug products; medical support devices, such as blood pressure monitors, nebulizer, kateter, and others; reaction materials, including blood sugar tests, pregnancy tests, or rapid tests for Covid19, drug tests, and others; and food supplements comprising minerals and nutrients. It also provides products for beauty and skin care, including makeup, perfume, skin nutrition, and other products; and daily cleaning and hygiene equipment and supplies, such as soaps, shampoos, toothpastes, lotions, and others. The company distributes its products to government hospitals, private hospitals, drug stores, medical device stores, clinics, and pharmacies. PT. Penta Valent Tbk was founded in 1968 and is headquartered in Kebon Jeruk, Indonesia.

www.pentavalent.co.id

1,019

Full Time Employees

December 31

Fiscal Year Ends

Related News

Performance Overview: PEVE.JK

Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

PEVE.JK
24.71%
IDX COMPOSITE
3.25%

1-Year Return

PEVE.JK
26.19%
IDX COMPOSITE
3.14%

3-Year Return

PEVE.JK
--
IDX COMPOSITE
2.55%

5-Year Return

PEVE.JK
--
IDX COMPOSITE
2.55%

Compare To: PEVE.JK

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: PEVE.JK

Valuation Measures

Annual
As of 4/26/2024
  • Market Cap

    374.31B

  • Enterprise Value

    374.31B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    1.46%

  • Return on Assets (ttm)

    3.71%

  • Return on Equity (ttm)

    19.09%

  • Revenue (ttm)

    2.48T

  • Net Income Avi to Common (ttm)

    36.17B

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    4.49B

  • Total Debt/Equity (mrq)

    33.55%

  • Levered Free Cash Flow (ttm)

    -69.72B

Company Insights: PEVE.JK

People Also Watch